Soft X-ray Tomography Reveals HSV-1-Induced Remodeling of Human B Cells.

HSV-1 X-ray tomography cell mapping cryo imaging infection imaging soft X-rays

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 11 2022
Historique:
received: 05 10 2022
revised: 21 11 2022
accepted: 23 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Upon infection, viruses hijack the cell machinery and remodel host cell structures to utilize them for viral proliferation. Since viruses are about a thousand times smaller than their host cells, imaging virus-host interactions at high spatial resolution is like looking for a needle in a haystack. Scouting gross cellular changes with fluorescent microscopy is only possible for well-established viruses, where fluorescent tagging is developed. Soft X-ray tomography (SXT) offers 3D imaging of entire cells without the need for chemical fixation or labeling. Here, we use full-rotation SXT to visualize entire human B cells infected by the herpes simplex virus 1 (HSV-1). We have mapped the temporospatial remodeling of cells during the infection and observed changes in cellular structures, such as the presence of cytoplasmic stress granules and multivesicular structures, formation of nuclear virus-induced dense bodies, and aggregates of capsids. Our results demonstrate the power of SXT imaging for scouting virus-induced changes in infected cells and understanding the orchestration of virus-host remodeling quantitatively.

Identifiants

pubmed: 36560654
pii: v14122651
doi: 10.3390/v14122651
pmc: PMC9781670
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM138441
Pays : United States
Organisme : NIH HHS
ID : P30GM138441
Pays : United States
Organisme : NIH HHS
ID : P41GM103445
Pays : United States

Références

Mol Biol Cell. 2019 Jan 1;30(1):131-145
pubmed: 30379612
Nat Commun. 2020 Jun 9;11(1):2905
pubmed: 32518228
Nat Commun. 2015 Jan 22;6:5980
pubmed: 25609143
Adv Virus Res. 2007;70:101-82
pubmed: 17765705
Science. 2000 May 5;288(5467):877-80
pubmed: 10797014
EMBO J. 2012 Nov 5;31(21):4204-20
pubmed: 22990238
J Virol. 1995 Feb;69(2):825-33
pubmed: 7815549
STAR Protoc. 2022 Feb 10;3(1):101176
pubmed: 35199039
Cell Rep Methods. 2021 Nov 22;1(7):100117
pubmed: 34729550
Sci Rep. 2016 Jun 28;6:28844
pubmed: 27349677
Trends Cell Biol. 2009 Nov;19(11):587-95
pubmed: 19818625
J Virol. 2002 Oct;76(20):10365-73
pubmed: 12239313
Cell. 2020 Jul 23;182(2):515-530.e17
pubmed: 32610083
Biophys J. 2014 Oct 21;107(8):1988-1996
pubmed: 25418180
J Virol. 2007 Oct;81(20):11468-78
pubmed: 17686835
Cell Rep. 2016 Nov 15;17(8):2125-2136
pubmed: 27851973
PLoS Pathog. 2022 Jul 7;18(7):e1010629
pubmed: 35797345
Viruses. 2021 Apr 02;13(4):
pubmed: 33918371
Microbes Infect. 2019 Jan - Feb;21(1):20-32
pubmed: 29953921
J Struct Biol. 2012 Feb;177(2):212-23
pubmed: 22273540
Elife. 2016 Sep 07;5:
pubmed: 27602576
Elife. 2017 May 13;6:
pubmed: 28500755
J Cell Biol. 2021 Sep 6;220(9):
pubmed: 34160561
Front Microbiol. 2020 May 07;11:733
pubmed: 32457704
Yeast. 2011 Mar;28(3):227-36
pubmed: 21360734
J Biol Chem. 2021 Jan-Jun;296:100236
pubmed: 33380421
Front Cell Infect Microbiol. 2019 Mar 04;9:42
pubmed: 30886834
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Struct Biol. 2012 Feb;177(2):267-72
pubmed: 22119891
J Virol. 2018 Jul 17;92(15):
pubmed: 29793959
Biophys Rev. 2019 Jul 8;:529-530
pubmed: 31286400
Ultramicroscopy. 2000 Aug;84(3-4):185-97
pubmed: 10945329
Mol Metab. 2022 Mar;57:101421
pubmed: 34942399
Front Microbiol. 2019 Jan 07;9:3255
pubmed: 30666247
Curr Opin Struct Biol. 2019 Oct;58:324-332
pubmed: 31495562
Virology. 2018 Sep;522:81-91
pubmed: 30014861
PLoS Pathog. 2009 Oct;5(10):e1000619
pubmed: 19816571
Emerg Top Life Sci. 2018 Apr 20;2(1):81-92
pubmed: 33525785
Biochim Biophys Acta Mol Basis Dis. 2022 Apr 1;1868(4):166347
pubmed: 35032594
Bioessays. 2012 Apr;34(4):320-7
pubmed: 22290620
PLoS Pathog. 2019 Dec 2;15(12):e1008209
pubmed: 31790506
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Virol. 2003 Mar;77(6):3680-9
pubmed: 12610143
J Struct Biol. 2012 Feb;177(2):259-66
pubmed: 22155289
F1000Res. 2019 Feb 18;8:198
pubmed: 31249678
J Virol. 1998 May;72(5):3779-88
pubmed: 9557660
Viruses. 2019 Oct 11;11(10):
pubmed: 31614678
Science. 2003 Nov 21;302(5649):1396-8
pubmed: 14631040

Auteurs

Jian-Hua Chen (JH)

Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA.

Bieke Vanslembrouck (B)

Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA.

Axel Ekman (A)

Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.

Vesa Aho (V)

Department of Biological and Environmental Science, Nanoscience Center, University of Jyvaskyla, 40014 Jyvaskyla, Finland.

Carolyn A Larabell (CA)

Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA.

Mark A Le Gros (MA)

Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA.

Maija Vihinen-Ranta (M)

Department of Biological and Environmental Science, Nanoscience Center, University of Jyvaskyla, 40014 Jyvaskyla, Finland.

Venera Weinhardt (V)

Centre for Organismal Studies, University of Heidelberg, 69120 Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH